EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Perfusion Assessment in CEUS Imaging for Estimating Pancreatic Cancer Response to Sonoporation-Enhanced Chemotherapy

Omri Adler iD, Priscilla Machado, Trang Vu, Flemming Forsberg iD, Odd Helge Gilja, Dan Adam iD

Ultrasonic Imaging · 2026-01 · 48 (1) · 36-52

DOI: 10.1177/01617346251367758 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Ultrasonic Imaging, online erschienen am 24.10.2025. Verfasst von Omri Adler und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Faculty of Bio-Medical Engineering, Technion Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Contrast Media, Neovascularization, Pathologic, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of perfusion in vital organs like the pancreas is crucial for monitoring various pathologies, particularly tumors and their growth. While tumor growth inhibition usually results in decreased vascularization, current techniques for non-invasive and cost-effective perfusion assessment lack sufficient vessel separability for pancreatic applications, hindering optimal treatment selection and monitoring. Ultrasound (US) imaging offers advantages like low cost, rapid acquisition, non-invasiveness, and non-ionizing radiation. However, speckle, patient-related and acquisition-related motion artifacts, and limitations in distinguishing contrast-enhanced blood vessels, particularly in single frames, pose significant challenges. This study presents a novel solution utilizing image analysis of US contrast agents (UCAs) to characterize vascularization. The approach involves data denoising, selection of static frames, spatio-temporal registration, and deconvolution. The post-processed images are analyzed based on temporal intensity changes and normalized to extract trends. Data from 13 patients undergoing chemotherapeutic treatment with FOLFIRINOX or gemcitabine/abraxane were analyzed. Though no direct effects on vascularization are expected, the results suggest a correlation between derived vascularization trends (based on B-mode and CEUS data) and observed clinical treatment outcomes. Four patients exhibited negative slope (related to vascularization regression) aligned with clinical improvement, while six showed positive slope (related to increased vascularization) coinciding with treatment deterioration. Two patients displayed negative slopes without clinical improvement, and one patient displayed positive slope but had clinical improvement. These findings indicate the potential of this method to estimate treatment efficacy and guide personalized therapy, although the sample size is small and further investigation is warranted. Trial Registry Name: Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer. URL: https://clinicaltrials.gov/study/NCT04821284 . Registration Number: NCT04821284.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsContrast MediaNeovascularization, PathologicPancreatic NeoplasmsAgedFemaleHumansMaleMiddle AgedAlbuminsDeoxycytidineFluorouracilGemcitabineIrinotecanLeucovorinOxaliplatinPancreasTreatment OutcomeUltrasonographyPaclitaxel

Stichwörter der Autor:innen

deconvolutionimage processingpancreatic cancerperfusionsonoporationultrasoundvascularization

Substanzen

130-nm albumin-bound paclitaxelAlbuminsContrast MediaDeoxycytidineFluorouracilfolfirinoxGemcitabineIrinotecanLeucovorinOxaliplatin

Autor:innen und Institutionen

  • The Faculty of Bio-Medical Engineering, Technion Israel Institute of Technology, Haifa, Israel.
  • The Radiology Department, Thomas Jefferson University, Philadelphia, PA, USA.
  • The Internal Medicine Department, Helse Bergen HF, Bergen, Norway.

ORCID-Profile: Omri Adler, Flemming Forsberg, Dan Adam

Förderung

  • NCI NIH HHS

Zitieren

APA

Adler, O., Machado, P., Vu, T., Forsberg, F., Gilja, O. H., & Adam, D. (2026). Perfusion Assessment in CEUS Imaging for Estimating Pancreatic Cancer Response to Sonoporation-Enhanced Chemotherapy. Ultrasonic Imaging, 48(1), 36-52. https://doi.org/10.1177/01617346251367758

Vancouver

Adler O, Machado P, Vu T, Forsberg F, Gilja OH, Adam D. Perfusion Assessment in CEUS Imaging for Estimating Pancreatic Cancer Response to Sonoporation-Enhanced Chemotherapy. Ultrasonic Imaging. 2026;48(1):36-52. doi:10.1177/01617346251367758

BibTeX
@article{Adler2026,
  author = {Adler, Omri and Machado, Priscilla and Vu, Trang and Forsberg, Flemming and Gilja, Odd Helge and Adam, Dan},
  title = {Perfusion Assessment in CEUS Imaging for Estimating Pancreatic Cancer Response to Sonoporation-Enhanced Chemotherapy},
  journal = {Ultrasonic Imaging},
  year = {2026},
  volume = {48},
  number = {1},
  pages = {36--52},
  doi = {10.1177/01617346251367758}
}
Kostenlos starten →